Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors

Journal of Proteome Research

Volumn 8, Issue 8, 2009, Pages 3987-3994

  Rignall, Benjamin ^a   Ittrich, Carina ^b   Krause, Eberhard ^c   Appel, Klaus E ^d   Buchmann, Albrecht ^a   Schwarz, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^d FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

B raf; Ha ras; Hepatocarcinogenesis; Microarray analysis; Mouse liver tumors; Proteomics

Indexed keywords

B RAF KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOME; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B RAF ONCOGENE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; LIVER TUMOR; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANIMALS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENOTYPE; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C3H; MUTATION; PROTEOMICS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RNA, MESSENGER;

EID: 68549094627     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr9002933     Document Type: Article

References (36)

1. Aydinlik, H.; Nguyen, T. D.; Moennikes, O.; Buchmann, A.; Schwarz, M. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 2001, 20, 7812-7816.
2. Calvisi, D. F.; Ladu, S.; Factor, V. M.; Thorgeirsson, S. S. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital. Carcinogenesis 2004, 25, 901-908.
3. Strathmann, J.; Schwarz, M.; Tharappel, J. C.; Glauert, H. P.; Spear, B. T.; Robertson, L. W.; Appel, K. E.; Buchmann, A. PCB 153, a non-dioxin-like tumor promoter, selects for beta-catenin (Catnb)-mutated mouse liver tumors. Toxicol. Sci. 2006, 93, 34-40.
4. Buchmann, A.; Bauer-Hofmann, R.; Mahr, J.; Drinkwater, N. R.; Luz, A.; Schwarz, M. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 911-915.
5. Jaworski, M.; Buchmann, A.; Bauer, P.; Riess, O.; Schwarz, M. B-raf and Ha-ras mutations in chemically induced mouse liver tumors. Oncogene 2005, 24, 1290-1295.
6. Buchmann, A.; Karcier, Z.; Schmid, B.; Strathmann, J.; Schwarz, M. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. Mutat. Res. 2008, 638, 66-74.
7. Hagemann, C.; Rapp, U. R. Isotype-specific functions of Raf kinases. Exp. Cell Res. 1999, 253, 34-46.
8. Mercer, K. E.; Pritchard, C. A. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta 2003, 1653, 25-40.
9. Wellbrock, C.; Karasarides, M.; Marais, R. The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 2004, 5, 875-885.
10. Malumbres, M.; Barbacid, M. RAS oncogenes: the first 30 years. Nat. Rev. Cancer 2003, 3, 459-465.
11. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 2003, 3, 11-22.
12. Jaworski, M.; Ittrich, C.; Hailfinger, S.; Bonin, M.; Buchmann, A.; Schwarz, M.; Köhle, C. Global gene expression in Ha-ras and B-raf mutated mouse liver tumors. Int. J. Cancer 2007, 121, 1382-1385.
13. Chen, G.; Gharib, T. G.; Huang, C. C.; Taylor, J. M.; Misek, D. E.; Kardia, S. L.; Giordano, T. J.; Iannettoni, M. D.; Orringer, M. B.; Hanash, S. M.; Beer, D. G. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 2002, 1, 304-413.
14. Tian, Q.; Stepaniants, S. B.; Mao, M.; Weng, L.; Feetham, M. C.; Doyle, M. J.; Yi, E. C.; Dai, H.; Thorsson, V.; Eng, J.; Goodlett, D.; Berger, J. P.; Gunter, B.; Linseley, P. S.; Stoughton, R. B.; Aebersold, R.; Collins, S. J.; Hanlon, W. A.; Hood, L. E. Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol. Cell. Proteomics 2004, 3, 960-969.
15. Schmidt, M. W.; Houseman, A.; Ivanov, A. R.; Wolf, D. A. Comparative proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe. Mol. Syst. Biol. 2007, 3, 79.
16. Griffin, T. J.; Gygi, S. P.; Ideker, T.; Rist, B.; Eng, J.; Hood, L.; Aebersold, R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteomics 2002, 1, 323-333.
17. Washburn, M. P.; Koller, A.; Oshiro, G.; Ulaszek, R. R.; Plouffe, D.; Deciu, C.; Winzeler, E.; Yates, J. R. 3rd. Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3107-3112.
18. Maziarz, M.; Chung, C.; Drucker, D. J.; Emili, A. Integrating global proteomic and genomic expression profiles generated from islet alpha cells: opportunities and challenges to deriving reliable biological inferences. Mol. Cell. Proteomics 2005, 4, 458-74.
19. Unwin, R. D.; Whetton, A. D. Systematic proteome and transcriptome analysis of stem cell populations. Cell Cycle 2006, 5, 1587-1591.
20. Stahl, S.; Ittrich, C.; Marx-Stoelting, P.; Koehle, C.; Altug-Teber, O.; Riess, O.; Bonin, M.; Jobst, J.; Kaiser, S.; Buchmann, A.; Schwarz, M. Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology 2005, 42, 353-361.
21. Jaworski, M.; Hailfinger, S.; Buchmann, A.; Hergenhahn, M.; Hollstein, M.; Ittrich, C.; Schwarz, M. Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53. Carcinogenesis 2005, 26, 1829-1834.
22. Buchmann, A.; Mahr, J.; Bauer-Hofmann, R.; Schwarz, M. Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse. Mol. Carcinog. 1989, 2, 121-125.
23. Strathmann, J.; Paal, K.; Ittrich, C.; Krause, E.; Appel, K. E.; Glauert, H. P.; Buchmann, A.; Schwarz, M. Proteome analysis of chemically induced mouse liver tumors with different genotype. Proteomics 2007, 7, 3318-3331.
24. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the priciple of proteindye binding. Anal. Biochem. 1976, 139, 248-254.
25. R-Development-Core-Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2005.
26. Wolfinger, R. D.; Gibson, G.; Wolfinger, E. D.; Bennett, L.; Hamadeh, H.; Bushel, P.; Afshari, C.; Paules, R. S. Assessing gene significance from cDNA microarray expression data via mixed models. J.Comput. Biol. 2001, 8, 625-37.
27. Hailfinger, S.; Jaworski, M.; Braeuning, A.; Buchmann, A.; Schwarz, M. Zonal gene expression in murine liver: Lessons from tumors. Hepatology 2006, 43, 407-414.
28. Braeuning, A.; Menzel, M.; Kleinschnitz, E. M.; Harada, N.; Tamai, Y.; Koehle, C.; Buchmann, A.; Schwarz, M. Serum components and activated Ha-ras antagonize expression of perivenous markers stimulated by beta-catenin in mouse hepatocytes. FEBS J. 2007, 274, 4766-4777.
29. Maser, E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem. Pharmacol. 1995, 49, 421-440.
30. Brose, M. S.; Volpe, P.; Feldman, M.; Kumar, M.; Rishi, I.; Gerrero, R.; Einhorn, E.; Herlyn, M.; Minna, J.; Nicholson, A.; Roth, J. A.; Albelda, S. M.; Davies, H.; Cox, C.; Brignell, G.; Stephens, P.; Futreal, P. A.; Wooster, R.; Stratton, M. R.; Weber, B. L. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002, 62, 6997-7000.
31. Futcher, B.; Latter, G. I.; Monardo, P.; McLaughlin, C. S.; Garrels, J. I. A sampling of the yeast proteome. Mol. Cell. Biol. 1999, 19, 7357-7368.
32. Greenbaum, D.; Colangelo, C.; Williams, K.; Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale. GenomeBiology 2003, 4, 117.
33. Braeuning, A.; Ittrich, C.; Koehle, C.; Buchmann, A.; Schwarz, M. Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas. Drug Metab. Dispos. 2007, 35, 503-507.
34. Treisman, R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 1996, 8, 205-215.
35. Keyse, S. M. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008, 27, 253-261.
36. Blüthgen, N.; Legewie, S.; Kielbasa, S. M.; Schramme, A.; Tchernitsa, O.; Keil, J.; Solf, A.; Vingron, M.; Schäfer, R.; Herzel, H.; Sers, C. A. systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts. FEBS J. 2009, 276, 1024-1035.